SCHEMBL7998537

SCHEMBL7998537

COc1nc2ccccc2nc1-c1cccc(/C=C/Cc2csc(C)n2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.34
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 1/20 0.32
POLB P06746 1/20 0.32
LMNA P02545 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
ADORA3 P0DMS8 1/20 0.32
MAOB P27338 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HDAC1 Q13547 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
KMT2A Q03164 1/20 0.31
CHEK1 O14757 1/20 0.31
SLC6A3 Q01959 1/20 0.31
NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7999178 0.91 L3MBTL1 (0.33) L3MBTL1KDM4EALDH1A1MAPTHPGD
SCHEMBL8000644 0.89 L3MBTL1 (0.32) L3MBTL1KDM4EALDH1A1MAPTHPGD
SCHEMBL8008226 0.88 PKM (0.32) L3MBTL1KDM4EALDH1A1MAPTHPGD
SCHEMBL8005068 0.88 L3MBTL1 (0.31) L3MBTL1KDM4EALDH1A1MAPTHPGD
SCHEMBL8000613 0.82 L3MBTL1 (0.32) L3MBTL1KDM4EALDH1A1LMNAADORA3
SCHEMBL10292801 0.79 ALDH1A1 (0.33) KDM4EALDH1A1KMT2ASLC6A3
SCHEMBL10293206 0.79 SLC6A3 (0.33) L3MBTL1KDM4EALDH1A1MAPTHPGD
SCHEMBL10259721 0.79 SLC6A3 (0.33) MAPTSLC6A3
SCHEMBL7998466 0.78 PKM (0.36) KDM4EALDH1A1MAPTHPGDHDAC1
SCHEMBL10293216 0.78 SLC6A3 (0.32) KDM4EALDH1A1SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009134987-A1 DIFLUOROMETHYL-CONTAINING MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-11-05 WO disclosed